WallStreetZenWallStreetZen

NYSE: MRK
Merck & Co Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MRK past earnings growth

How has MRK's earnings growth performed historically?
Company
111.58%
Industry
39.51%
Market
40.4%
MRK's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MRK's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MRK's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MRK past revenue growth

How has MRK's revenue growth performed historically?
Company
27.84%
Industry
12.36%
Market
154.86%
MRK's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MRK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MRK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MRK earnings and revenue history

Current Revenue
$59.0B
Current Earnings
$15.3B
Current Profit Margin
25.9%
MRK's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

MRK Return on Equity

Current Company
36.6%
Current Industry
48.8%
Current Market
-8.3%
MRK's Return on Equity (36.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MRK announces earnings.

MRK Return on Assets

Current Company
14.3%
Current Industry
11.3%
MRK is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MRK Return on Capital Employed

Current Company
19.94%
Current Industry
17.8%
MRK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MRK vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MRK$58.97B$20.62B$15.26B+8.18%+42.12%
ABBV$57.82B$25.20B$13.41B+16.22%+12.65%
PFE$99.68B$38.03B$29.77B+13.69%+26.49%
LLY$29.24B$8.14B$6.03B+5.41%+25.80%
AZN$45.15B$8.60B$2.04B+15.18%-16.89%
View Top General Drug Manufacturer Stocks

MRK earnings dates

Next earnings date
Feb 2, 2023

Merck & Co Earnings & Revenue FAQ

What were MRK's earnings last quarter?

On Invalid Date, Merck & Co (NYSE: MRK) reported Q3 2022 earnings per share (EPS) of $1.28, up 29.28% year over year. Total Merck & Co earnings for the quarter were $3.25 billion. In the same quarter last year, Merck & Co's earnings per share (EPS) was $1.81.

If you're new to stock investing, here's how to buy Merck & Co stock.

What was MRK's earnings growth in the past year?

As of Q1 2023, Merck & Co's earnings has grown 111.58% year over year. This is 72.07 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 39.51%. Merck & Co's earnings in the past year totalled $15.26 billion.

What is MRK's earnings date?

Merck & Co's earnings date is Invalid Date. Add MRK to your watchlist to be reminded of MRK's next earnings announcement.

What was MRK's revenue last quarter?

On Invalid Date, Merck & Co (NYSE: MRK) reported Q3 2022 revenue of $14.96 billion up 13.72% year over year. In the same quarter last year, Merck & Co's revenue was $13.15 billion.

What was MRK's revenue growth in the past year?

As of Q1 2023, Merck & Co's revenue has grown 27.84% year over year. This is 15.48 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 12.36%. Merck & Co's revenue in the past year totalled $58.97 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.